Detailed analysis of CYP24A1 immunostaining in melanomas, stratified according to their Breslow’s thickness and Clark’s level, revealed comparable CYP24A1 levels in thin melanomas (Breslow < 2.0 mm and Clark I–II) and melanocytic nevi (Figure 2A,B). The gene discussed is CYP24A1; the disease is melanoma.